Reductions in the levels of H3K27me3 and H3K9me2 in MM cells treated with the EZH2/G9a inhibitors were confirmed by ChIP-qPCR analyses (Fig. 5C, D and Supplementary Fig. S8E, F). The gene discussed is EHMT2; the disease is Miyoshi myopathy.